康泰医学：关于继续延长使用暂时闲置募集资金进行现金管理授权期限的公告

Core Viewpoint - The company announced the approval of a proposal to use part of its temporarily idle raised funds for cash management, amounting to a maximum of 650 million RMB, while ensuring that it does not affect the normal investment plans and operations [1] Group 1 - The company will hold its fourth board meeting and second supervisory board meeting on August 8, 2023 [1] - The board approved the use of up to 650 million RMB of convertible bonds for cash management [1] - The usage period for these funds is valid for 12 months from the date of board approval [1]